Income StatementBalance SheetCash FlowSegments
CRH logo

CRH Cash Flow Statement

Operating, investing, and financing cash movements

CRH generated $5.7B in operating cash flow over the trailing twelve months. After $2.7B in capital expenditures, free cash flow was $3.0B. Free cash flow increased 0.3% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$5.7BNet Cash From Investing (TTM)-$5.8BNet Cash From Financing (TTM)$2.3BCapital Expenditures (TTM)$2.7BDepreciation And Amortization Cf (TTM)$2.0BNet Change In Cash (TTM)-$1.3B
Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$67.1B
P/E Ratio18.27
ROE16.61%

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other non-cash income (expense)-$31.0M$14.0M-$16.0M-$3.0M—-$9.0M
Share of Profits (Losses) of Related Party-$135.0M-$10.0M$1.0M$26.0M$9.0M-$11.0M
Change in Pension and Postretirement Obligations-$8.0M-$10.0M-$10.0M-$10.0M-$11.0M-$10.0M
Change in pension and postretirement obligations-$8.0M-$10.0M-$10.0M-$10.0M-$11.0M-$10.0M
Change in accounts payable$324.0M-$503.0M—-$206.0M—-$287.0M
Change in accounts receivable—$268.0M$1.1B$543.0M-$2.1B$478.0M
Change in inventories$179.0M$139.0M——$137.0M$156.0M
Change in other liabilities-$584.0M$72.0M$177.0M$383.0M—$128.0M
Deferred income taxes—$4.0M$1.0M$170.0M$0.0-$160.0M
Depreciation and amortization$510.0M$477.0M$528.0M——$576.0M
Pension and Other Postretirement Benefits Expense Reversal$7.0M$6.0M$6.0M$5.0M$4.0M$4.0M
Other Non-Cash Income (Expense)-$31.0M$14.0M-$16.0M-$3.0M—-$9.0M
Other Non-cash Income (Expense)-$31.0M$14.0M-$16.0M-$3.0M—-$9.0M
Income (Loss) from Equity Method Investments-$135.0M-$10.0M$1.0M$26.0M$9.0M-$11.0M
Other Non-cash Income (Expense)-$31.0M$14.0M-$16.0M-$3.0M—-$9.0M
Income (Loss) from Equity Method Investments-$135.0M-$10.0M$1.0M$26.0M$9.0M-$11.0M
Income (Loss) from Equity Method Investments-$135.0M-$10.0M$1.0M$26.0M$9.0M-$11.0M
Net cash from operating activities$2.7B-$659.0M$1.4B$2.0B$2.9B-$616.0M
Net income$709.0M-$98.0M$1.3B$1.5B$1.0B-$180.0M
Other non-cash income (expense)-$31.0M$14.0M-$16.0M-$3.0M—-$9.0M
Asset write-downs$40.3M$0.0———$48.0M
Gain (Loss) on Disposition of Assets$42.0M-$1.0M$13.0M$114.0M$121.0M$16.0M
Equity in earnings (losses) of equity method investees-$135.0M-$10.0M$1.0M$26.0M$9.0M-$11.0M
Operating lease liabilities-$69.0M-$78.0M-$75.0M-$73.0M-$84.0M-$86.0M
Increase (Decrease) in Other Operating Assets—$210.0M$40.0M—$47.0M$131.0M
Pension and other postretirement plans-$8.0M-$10.0M-$10.0M-$10.0M-$11.0M-$10.0M
Operating lease right-of-use asset amortization$74.0M$59.0M$75.0M$74.0M$84.0M$83.0M
Other Noncash Income (Expense)-$31.0M$14.0M-$16.0M-$3.0M—-$9.0M
Pension and other postretirement income$7.0M$6.0M$6.0M$5.0M$4.0M$4.0M
Other Non-cash Income and Expense-$31.0M$14.0M-$16.0M-$3.0M—-$9.0M
Other Non-Cash Adjustments-$31.0M$14.0M-$16.0M-$3.0M—-$9.0M
Other Non-Cash Income and Expense-$31.0M$14.0M-$16.0M-$3.0M—-$9.0M
Income (Loss) from Equity Method Investments-$135.0M-$10.0M$1.0M$26.0M$9.0M-$11.0M
Stock-based compensation$29.0M$32.0M$34.0M$38.0M$39.0M$29.0M
Change in Pension and Postretirement Obligations-$8.0M-$10.0M-$10.0M-$10.0M-$11.0M-$10.0M
Change in pension and postretirement obligations-$8.0M-$10.0M-$10.0M-$10.0M-$11.0M-$10.0M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Payment for contingent consideration liability (financing)$5.0M$11.0M$2.0M$15.0M$3.0M$12.0M
Net proceeds (payments) from derivative instrument financing activities$70.0M-$15.0M-$62.0M-$43.0M-$1.0M$15.0M
Payment for Contingent Consideration (Financing)$5.0M$11.0M$2.0M$15.0M$3.0M$12.0M
Distributions to noncontrolling interests$20.0M$17.0M$5.0M$9.0M$3.0M$15.0M
Finance Lease, Principal Payments$20.0M$21.0M$25.0M$27.0M$58.0M$37.0M
Payments For (Proceeds From) Employee Share Plans-$5.0M-$1.0M$57.0M——-$2.0M
Proceeds from issuances of debt$549.0M$3.0B$1.5B$3.2B$2.7B$1.2B
Proceeds From Payments To Minority Shareholders$19.0M$0.0$2.0M$0.0$26.0M-$24.0M
Repayments of Debt$5.0M$1.5B$1.8B$345.0M$3.9B$207.0M
Net Cash from Derivative Financing Activities$70.0M-$15.0M-$62.0M-$43.0M-$1.0M$15.0M
Cash Flows from Financing Derivatives$70.0M-$15.0M-$62.0M-$43.0M-$1.0M$15.0M
Finance lease prepayments$20.0M$21.0M$25.0M$27.0M$58.0M$37.0M
Payment of Deferred Purchase Consideration$5.0M$11.0M$2.0M$15.0M$3.0M$12.0M
Net cash from financing activities-$42.0M$1.1B-$1.2B$2.3B—$572.0M
Repurchases of common stock$258.0M$310.0M$334.0M$286.0M$251.0M$332.0M

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired$1.0B$585.0M$63.0M$2.5B$735.0M$126.0M
Capital expenditures$943.0M$645.0M$655.0M$592.0M$821.0M$601.0M
Payments for Derivative Instruments (Investing)—-$20.0M$53.0M$39.0M$9.0M$24.0M
Proceeds from Derivative Instrument Investing Activities—-$20.0M$53.0M$39.0M—$24.0M
Payments for (Proceeds from) Derivative Instruments, Investing—-$20.0M$53.0M$39.0M—$24.0M
Payments for (Proceeds from) Derivative Instrument, Investing Activities—-$20.0M$53.0M$39.0M—$24.0M
Payment for (Proceeds from) Other Investing Activity$24.0M-$130.0M—-$49.0M—$5.0M
Deferred divestiture consideration received$1.0M$36.0M$2.0M$2.0M$2.0M$0.0
Divestiture of businesses, net of cash transferred$24.0M$36.0M$1.0M$15.0M$87.0M$6.0M
Proceeds from disposals of property, plant and equipment$69.0M$35.0M$30.0M$118.0M$132.0M$28.0M
Net cash from investing activities-$1.9B-$964.0M-$831.0M-$2.9B-$1.3B-$722.0M
Dividend Received from Consumer Healthcare JV$22.0M$9.0M$4.0M$10.0M$27.0M$0.0
Investing Cash Flows from Derivatives—-$20.0M$53.0M$39.0M—$24.0M
Proceeds from divestiture of prepaid business$24.0M$36.0M$1.0M$15.0M$87.0M$6.0M
Payments for (Proceeds from) Derivative Instruments, Investing—-$20.0M$53.0M$39.0M—$24.0M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$1.8B-$1.3B$723.0M$1.4B$2.1B-$1.2B

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income taxes paid$306.0M$134.0M$170.0M$76.0M$451.0M$39.0M
Interest paid$227.0M$63.0M$188.0M$243.0M$230.0M$160.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Contingent consideration (receivable) payable - financing activities$5.0M$11.0M$2.0M$15.0M$3.0M$12.0M
Net increase (decrease) in cash—-$407.0M-$476.0M$1.4B—-$814.0M
FX Effect on Cash from Discontinued Operations-$123.0M$75.0M$130.0M$0.0$7.0M-$48.0M